Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
| Primary Drug | Male | Female | Total | |
|---|---|---|---|---|
| Opioids | 35 | 33 | 34 | |
| Cocaine | 33 | 32 | 33 | |
| Stimulants | 30 | 28 | 29 | |
| Hypnotics and sedatives | 36 | 41 | 38 | |
| Hallucinogens | 27 | 26 | 27 | |
| Volatile inhalants | 22 | 21 | 22 | |
| Cannabis | 25 | 25 | 25 | |
| Other substances | 33 | 37 | 34 | |
| TOTAL | 32 | 31 | 31 |
The countries supplying data are:
BE, BG, CZ, DK, DE, IE, EE, GR, ES, FR, IT, CY, LU, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, UK, HR.
See also ‘General notes for interpreting data’ on the Explanatory notes and help page.
Reitox national reports 2011 — TDI — outpatient treatment centres.
Page last updated: Monday, 09 July 2012